Yumanity Therapeutics announces publication of paper in Cell Reports
The company's discovery engine identified a series of compounds that shielded cells against alpha-synuclein-induced toxicity by inhibiting stearoyl-CoA desaturase. This finding suggests that inhibition of fatty acid desaturation could be a potential therapeutic approach for treating Parkinson's disease and other synuclein-based disorders.